Teyi Pharmaceutical Group Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Teyi Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Zhejiang Starry Pharmaceutical Co Ltd
sales of 890.47 million Chinese Renmimbi [US$126.51 million]
of which 84%
was Contrast Agent),
Honz Pharmaceutical Co Ltd
(882.66 million Chinese Renmimbi [US$125.40 million]
of which 57%
was Pharmaceutical Production and Sales Repo), and
Shang Hai Kai Kai Industry Co Ltd
(877.57 million Chinese Renmimbi [US$124.68 million]
Teyi Pharmaceutical Group Co Ltd reported sales of 884.98 million Chinese Renmimbi (US$125.73 million)
December of 2018.
increase of 28.8%
versus 2017, when the company's sales were 686.94 million Chinese Renmimbi.
Sales at Teyi Pharmaceutical Group Co Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 158%).
Sales of Pharmaceutical Industry saw an increase
31.6% in 2018, from
641.35 million Chinese Renmimbi to 844.24 million Chinese Renmimbi.
Not all segments of Teyi Pharmaceutical Group Co Ltd experienced an increase in sales in 2018:
sales of Pharmaceutical Business fell 13.8% to 22.24 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).